Publications by authors named "Albinski M"
Article Synopsis
- - High-level sports competition is trending among Swiss youth, but there's inconsistency in screening for diseases that could lead to sudden death in athletes, prompting the need for age-specific cardiovascular evaluations for those under 18.
- - Starting at age 12, athletes training over 6 hours a week should undergo preparticipation cardiovascular evaluations that include medical history checks and physical exams; a standard ECG is recommended for those older than 15.
- - Regular follow-ups are advised, even for athletes with normal evaluations, and further investigation is recommended for those with abnormal findings, while individuals with congenital heart disease require specialized care.
Objectives: Athletes performing sports on high level are at increased risk for sudden cardiac death. This includes paediatric athletes, even though data on screening strategies in this age group remain scarce. This study aimed to assess electrocardiogram interpretation criteria in paediatric athletes and to evaluate the cost of screening.
View Article and Find Full Text PDFAthletes of pediatric age are growing in number. They are subject to a number of risks, among them sudden cardiac death (SCD). This study aimed to characterize the pediatric athlete population in Switzerland, to evaluate electrocardiographic findings based on the International Criteria for electrocardiography (ECG) Interpretation in Athletes, and to analyze the association between demographic data, sport type, and ECG changes.
View Article and Find Full Text PDFAims Of The Study: Paediatric musculoskeletal infections by Panton-Valentine leucocidin (PVL)-producing Staphylococcus aureus constitute a rare, but highly critical event. They are characterised by a rapid course of marked inflammation, worsening under conservative therapy and a high rate of recurrence. This study aimed to illustrate the importance of paediatric PVL-producing S.
View Article and Find Full Text PDFAntiphospholipid Syndrome (APS) describes a systemic disease caused by autoantibodies to membrane components. Involving coagulation pathways, complement factors and immune cells, it results in thrombosis in any blood vessel. Its clinical presentation varies considerably depending upon the organ affected.
View Article and Find Full Text PDFAutomating the laboratory for computerized lot release operations.
J Parenter Sci Technol
January 1986